- Home
- XAIR vs OMGA Comparison
XAIR vs OMGA Comparison
Compare XAIR & OMGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XAIR
- OMGA
- Stock Information
- Founded
- XAIR 2011
- OMGA 2017
- Country
- XAIR United States
- OMGA United States
- Employees
- XAIR N/A
- OMGA N/A
- Industry
- XAIR Medical/Dental Instruments
- OMGA Biotechnology: Pharmaceutical Preparations
- Sector
- XAIR Health Care
- OMGA Health Care
- Exchange
- XAIR Nasdaq
- OMGA Nasdaq
- Market Cap
- XAIR 27.7M
- OMGA 27.1M
- IPO Year
- XAIR N/A
- OMGA 2021
- Fundamental
- Price
- XAIR $0.35
- OMGA $0.16
- Analyst Decision
- XAIR Strong Buy
- OMGA Strong Buy
- Analyst Count
- XAIR 4
- OMGA 5
- Target Price
- XAIR $3.67
- OMGA $9.20
- AVG Volume (30 Days)
- XAIR 1.4M
- OMGA 26.1M
- Earning Date
- XAIR 02-10-2025
- OMGA 03-27-2025
- Dividend Yield
- XAIR N/A
- OMGA N/A
- EPS Growth
- XAIR N/A
- OMGA N/A
- EPS
- XAIR N/A
- OMGA N/A
- Revenue
- XAIR $3,023,000.00
- OMGA $8,095,000.00
- Revenue This Year
- XAIR $244.61
- OMGA $181.38
- Revenue Next Year
- XAIR $258.76
- OMGA N/A
- P/E Ratio
- XAIR N/A
- OMGA N/A
- Revenue Growth
- XAIR 338.75
- OMGA 185.04
- 52 Week Low
- XAIR $0.30
- OMGA $0.10
- 52 Week High
- XAIR $2.11
- OMGA $4.46
- Technical
- Relative Strength Index (RSI)
- XAIR 41.74
- OMGA 31.40
- Support Level
- XAIR $0.34
- OMGA $0.15
- Resistance Level
- XAIR $0.40
- OMGA $0.25
- Average True Range (ATR)
- XAIR 0.05
- OMGA 0.08
- MACD
- XAIR -0.00
- OMGA 0.01
- Stochastic Oscillator
- XAIR 10.21
- OMGA 16.02
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About OMGA Omega Therapeutics Inc.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.